Stories

Corporate

Mar 17, 2022
Novartis opens facility for innovative cell and gene therapies in Switzerland
Corporate
Education Awareness

Mar 17, 2022
Introducing the Immune Thrombocytopenia (ITP) Pocket Log
Education Awareness
Education Awareness

Mar 17, 2022
Visionary: Silke Mader has a vision for the care of premature infants and their parents
Education Awareness
Education Awareness

Mar 17, 2022
MS Explored - An Informational Meeting for Young People Living with Multiple Sclerosis in Ireland
Education Awareness
Education Awareness

Mar 17, 2022
4th annual European Patient Innovation Summit #EPIS
Education Awareness
Corporate

Mar 17, 2022
Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence
Corporate
Education Awareness

Mar 17, 2022
National tour launched to highlight the symptoms of Age-Related Macular Degeneration with new online Symptom Checker
Education Awareness
Education Awareness

Mar 17, 2022
Novartis Ireland launch My Migraine Voice Survey Report in Cork
Education Awareness
Education Awareness

Mar 17, 2022
A Recent Survey Shows that 44% of Irish People have Poor Understanding of the Symptoms and Nature of Multiple Sclerosis (MS)
A survey commissioned by MS Ireland and Novartis Ireland to mark World MS Day 2019 explores the public’s awareness of the visible and invisible symptoms of MS.
Education Awareness
Education Awareness

Mar 17, 2022
Don't Ignore the Signs of Heart Failure, Warns Michael Lyster
Education Awareness
Education Awareness

Mar 17, 2022
MS Explored Meeting
Education Awareness
Corporate

Mar 17, 2022
Novartis Signs Collaboration Agreement to Fund Medtech Development of Low Cost Eye Monitor
Corporate